Bill Text: NY S05704 | 2023-2024 | General Assembly | Introduced
Bill Title: Limits the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; provides for professional misconduct for any health care professional who uses such drug on such patient.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-01-03 - REFERRED TO HEALTH [S05704 Detail]
Download: New_York-2023-S05704-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 5704 2023-2024 Regular Sessions IN SENATE March 13, 2023 ___________ Introduced by Sen. COMRIE -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to limiting the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; and to amend the education law, in relation to professional medical misconduct The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The public health law is amended by adding a new section 2 280-d to read as follows: 3 § 280-d. Use of antipsychotic drugs on elderly patients with dementia. 4 1. As used in this section: 5 (a) "off label" means a medical practice in which a physician 6 prescribes a drug for a different medical purpose than the one for which 7 such drug is approved for; 8 (b) "black box warning" means a warning issued by the federal Food and 9 Drug Administration and placed on the package insert of a prescription 10 drug that may be fatal or cause server side effects; 11 (c) "chemical restraint" means when an antipsychotic drug that 12 provides no medical benefit to a patient with dementia and is used to 13 sedate such patient, control such patient's behavior or restrict such 14 patient's movement; 15 (d) "antipsychotic drug" means any typical or atypical antipsychotic 16 drug that is intended to be used on patients with mental illness that 17 require a black box warning and shall include but not be limited to the 18 following: 19 (i) Typical antipsychotic drugs: haloperidol, loxapine, thioridazine, 20 molindone, thiothixene, fluphenazine, trifluoperazine, chlorpromazine, 21 perphenazine, or promozide; or EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD04705-01-3S. 5704 2 1 (ii) Atypical antipsychotic drugs: aripiprazole, lumapeterone, clozar- 2 il, iloperidone, ziprasidone, paliperidone, lurasidone, brexipiprazole, 3 risperidone, asenapine, quetiapine, cariprazine, or olanzapine; and 4 (e) "patient" means an elderly individual with dementia who is: 5 (i) a resident of a residential health care facility as defined in 6 article twenty-eight of this chapter or an adult care facility certified 7 under section four hundred sixty-one-b of the social services law; or 8 (ii) in the care of a hospital as defined in article twenty-eight of 9 this chapter, a facility as defined in article twenty of this chapter or 10 any other health care facility who care for individuals with dementia. 11 2. No antipsychotic drug that contains a black box warning shall be 12 used for an off label purpose on a patient known to have dementia or to 13 chemically restrain a patient known to have dementia. An order for an 14 antipsychotic drug may only be issued in an emergency situation and by a 15 health care professional who specializes in dementia or is specifically 16 trained in the treatment of dementia patients if such a patient is 17 agitated and where it is reasonably necessary to protect the life, 18 health or safety of the patient or another person. Where an order is 19 made under this subdivision, the health care professional shall imme- 20 diately record the use of the antipsychotic drug, the reason for the 21 use, and the dosage, in the patient's medical record; and shall promptly 22 notify the patient or the patient's lawful representative who would have 23 had the authority to consent that such drug with a black box warning was 24 used and any family member required to be notified under this section 25 and record such notifications in the patient's medical record. 26 3. This section does not increase the lawful scope of practice of any 27 health care professional and does not diminish or impair any requirement 28 for or regulation of consent to health care treatment. A health care 29 professional who fails to comply with the provisions of this section may 30 be found guilty of professional misconduct pursuant to article one 31 hundred thirty-one-a of the education law. 32 4. The commissioner may make rules or regulations to implement the 33 provisions of this section. 34 § 2. Section 6530 of the education law is amended by adding a new 35 subdivision 51 to read as follows: 36 51. Failing to comply with the provisions of section two hundred 37 eighty-d of the public health law. 38 § 3. This act shall take effect on the thirtieth day after it shall 39 have become a law. Effective immediately, the addition, amendment and/or 40 repeal of any rule or regulation necessary for the implementation of 41 this act on its effective date are authorized to be made and completed 42 on or before such effective date.